Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate) is a synthetic pyrimidine nucleotide analog and a phosphorylated derivative of the nucleoside analog 2'-deoxyuridine. It features a hydroxymethyl group at the C‑5 position of the uracil base and a monophosphate group at the C‑5' position of the deoxyribose sugar[1][4][7]. This compound belongs to the class of pyrimidine deoxyribonucleoside monophosphates[2]. **Mechanism & Use:** It has been studied for its anticancer and antiviral activities as well as its use as a diagnostic biomarker for oxidative stress in mammalian cells. Its incorporation into DNA can serve as an indicator of cancer or cellular oxidative damage[1]. The compound is primarily used in research settings; there are no approved therapeutic indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate).